290650 Stock Chart & Stats
₩47900.00
-₩700.00(-1.44%)
―
--
Day’s Range― - ―
52-Week Range₩32,009.32 - ₩120,881.11
Previous CloseN/A
VolumeN/A
Average Volume (3M)222.87K
Market Cap
₩1.47T
Enterprise Value₩2.42M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Nov 18, 2026EPS Estimate
252.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)136.30
Shares Outstanding30,595,703
10 Day Avg. Volume140,378
30 Day Avg. Volume222,873
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)532.73
Revenue Forecast (FY)₩167.83B
L&C BIO Co., Ltd. News
290650 FAQ
What was L&C BIO Co., Ltd.’s price range in the past 12 months?
L&C BIO Co., Ltd. lowest stock price was ₩32009.32 and its highest was ₩120881.11 in the past 12 months.
What is L&C BIO Co., Ltd.’s market cap?
L&C BIO Co., Ltd.’s market cap is ₩1.47T.
When is L&C BIO Co., Ltd.’s upcoming earnings report date?
L&C BIO Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 72 days.
How were L&C BIO Co., Ltd.’s earnings last quarter?
L&C BIO Co., Ltd. released its earnings results on Aug 11, 2026. The company reported ₩136.296 earnings per share for the quarter.
Is L&C BIO Co., Ltd. overvalued?
According to Wall Street analysts L&C BIO Co., Ltd.’s price is currently Undervalued.
Does L&C BIO Co., Ltd. pay dividends?
L&C BIO Co., Ltd. does not currently pay dividends.
What is L&C BIO Co., Ltd.’s EPS estimate?
L&C BIO Co., Ltd.’s EPS estimate is 252.16.
How many shares outstanding does L&C BIO Co., Ltd. have?
L&C BIO Co., Ltd. has 30,595,703 shares outstanding.
What happened to L&C BIO Co., Ltd.’s price movement after its last earnings report?
L&C BIO Co., Ltd. reported an EPS of ₩136.296 in its last earnings report. Following the earnings report the stock price went down -1.703%.
Which hedge fund is a major shareholder of L&C BIO Co., Ltd.?
Currently, no hedge funds are holding shares in KR:290650
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
GC Biopharma Corp.
―
Celltrion Pharm Inc.
―
Seegene, Inc.
―
Chong Kun Dang Pharmaceutical Corp.
―
HK inno.N Corporation
―